文献速递白血病

分子协同作用决定NPM1突变急性髓系白血病的共现模式与表型

Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
PubMed 文献 · Blood · 2017-08-23

研究在敲入小鼠中比较NPM1突变分别合并FLT3-ITD或NRAS/KRAS突变对造血与白血病发生的影响,发现两种组合早期均出现Hox基因过表达、自我更新增强和祖细胞扩增,但NPM1c/FLT3-ITD表现出更强的分子协同和不同分化偏向,且两者均发生高外显率急性髓系白血病,NPM1c/NRAS-G12D潜伏期显著更长。

要点

  • NPM1c合并FLT3-ITD或NRAS-G12D均导致Hox基因过表达和造血祖细胞扩增。
  • NPM1c/FLT3-ITD外周血白细胞计数显著更高,伴共同淋巴祖细胞早期耗竭和单核细胞偏向。
  • 两种双突变模型均发生高外显率AML,NPM1c/NRAS-G12D潜伏期显著更长。

核心结论

  • 分子互补性解释了NPM1c/FLT3-ITD较NPM1/NRAS-G12D突变AML发生率更高且预后更差,并功能证实HOXA基因在NPM1c驱动AML中的作用。

研究设计与样本

  • 研究在敲入小鼠中比较NPM1cA/+;NrasG12D/+与Npm1cA;Flt3ITD两种突变组合对造血和白血病发生的影响。

主要发现

  • Npm1cA/+;NrasG12D/+或Npm1cA;Flt3ITD均出现Hox基因过表达、自我更新增强、造血祖细胞扩增和髓系分化偏向。
  • Npm1cA;Flt3ITD突变体外周血白细胞计数显著更高,共同淋巴祖细胞早期耗竭,呈单核细胞偏向;Npm1cA/+;NrasG12D/+突变体呈粒细胞偏向。
  • Npm1cA;Flt3ITD祖细胞基因表达谱较野生型发生显著改变,而Npm1cA/+;NrasG12D/+祖细胞未出现类似改变。
  • 两种双突变模型均发生高外显率AML,但Npm1cA/+;NrasG12D/+潜伏期显著更长。
  • 白血病演变过程中,两种模型均获得突变Flt3或Nras等位基因额外拷贝,但仅Npm1cA/+;NrasG12D/+小鼠获得其他人类AML突变,包括IDH1 R132Q。

关键数值与推荐

  • 使用原代表达Cas9的AML细胞发现,Hoxa基因及选定互作因子或下游靶点对两种双突变AML的生存均必需。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

NPM1 mutations define the commonest subgroup of acute myeloid leukemia (AML) and frequently co-occur with FLT3 internal tandem duplications (ITD) or, less commonly, NRAS or KRAS mutations. Co-occurrence of mutant NPM1 with FLT3-ITD carries a significantly worse prognosis than NPM1-RAS combinations. To understand the molecular basis of these observations, we compare the effects of the 2 combinations on hematopoiesis and leukemogenesis in knock-in mice. Early effects of these mutations on hematopoiesis show that compound Npm1cA/+;NrasG12D/+ or Npm1cA;Flt3ITD share a number of features: Hox gene overexpression, enhanced self-renewal, expansion of hematopoietic progenitors, and myeloid differentiation bias. However, Npm1cA;Flt3ITD mutants displayed significantly higher peripheral leukocyte counts, early depletion of common lymphoid progenitors, and a monocytic bias in comparison with the granulocytic bias in Npm1cA/+;NrasG12D/+ mutants. Underlying this was a striking molecular synergy manifested as a dramatically altered gene expression profile in Npm1cA;Flt3ITD , but not Npm1cA/+;NrasG12D/+ , progenitors compared with wild-type. Both double-mutant models developed high-penetrance AML, although latency was significantly longer with Npm1cA/+;NrasG12D/+ During AML evolution, both models acquired additional copies of the mutant Flt3 or Nras alleles, but only Npm1cA/+;NrasG12D/+ mice showed acquisition of other human AML mutations, including IDH1 R132Q. We also find, using primary Cas9-expressing AMLs, that Hoxa genes and selected interactors or downstream targets are required for survival of both types of double-mutant AML. Our results show that molecular complementarity underlies the higher frequency and significantly worse prognosis associated with NPM1c/FLT3-ITD vs NPM1/NRAS-G12D-mutant AML and functionally confirm the role of HOXA genes in NPM1c-driven AML.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Dovey OM, Cooper JL, Mupo A, et al. Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia. Blood. 2017. PMID: 28835438. doi:10.1182/blood-2017-01-760595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。